Special Masters Back Atty Fee Bid In $688M Vytorin Deal

Law360, New York (August 29, 2013, 3:04 PM EDT) -- Two special masters recommended Wednesday that a New Jersey federal court approve $140 million in attorneys’ fees sought by class counsel who settled for $688 million two securities class actions alleging Merck & Co. and its Schering-Plough subsidiary hid test results on the efficacy of their anti-cholesterol drug Vytorin.

Court-appointed special masters Stephen M. Greenberg and Jonathan J. Lerner strongly backed the attorneys’ fees and certain expense reimbursements sought by co-lead counsel for the class, saying they were reasonable, reflected the massive undertaking of five years'...
To view the full article, register now.